About this trial
The purpose of study is to build a Canadian HTPN Registry to collect pertinent demographic and clinical data on the HTPN population in Canada and to determine the factors affecting survival, complications and TPN-dependency. These results will help establish standards of practice and develop future multi-center studies. This will greatly benefit the HTPN patient population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with long-term administration of home total parenteral nutrition Age >18 years
Disqualifiers
None
Trial population
Patients receiving home total parenteral nutrition (HTPN)
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Nutritional status
Body weight, body mass index
Secondary outcomes
Patient characteristics
Age, sex, medical history
Medications
Immunosuppressors, motility agents, antidiarrheal, sedatives, antidepressors, anticoagulants, insulin, inhibitors of acid secretion, medication to treat liver disease (eg. urso, carnitine, choline…), medication to treat metabolic bone disease (eg. iv/oral calcium, vitamin D, biphosphonate, calcitonin,… are collected from the charts
Indications for HTPN
Short bowel, motility disorder, cancer, surgical complications, pancreatic disorders, other causes of malabsorption
Gastrointestinal anatomy
Anatomy as described in medical records
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Health Network, Toronto
Lead sponsor
Canadian Nutrition Society
Collaborator
Baxter Healthcare Corporation
Collaborator
Ontario Medical Supply
Collaborator